chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, Immediate post-injection reaction, Injection site pain, Muscle spasms, Myalgia
Clinical narrative: I immediately felt a severe muscle pain at the site of the injection. I went to home and iced the site. The second injection went into the same left arm. The nurse administering the second vaccine suggested same arm so my right arm would not be compromised. I have gone for PT to alleviate the muscle spasm. Now I am experiencing a continued series of muscle pain ranging in moderate to severe pain. The muscles affected are now in both my arms & legs. I have also tried acupuncture for pain relief. This is an ongoing pain to date.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was administered post use date. Patient's provider Dr. the contacted parents or guardian on 03/10/23 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was given 4th dose of monovalent vaccine instead of getting the bivalent booster.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ageusia, Anosmia, Arthralgia, Asthenia, COVID-19
Clinical narrative: I had my vaccination on 10/14/2022. On 04/02/2023 I started to have a sore throat. On the evening of 04/03/2023 I had the worst sore throat of my life. I had congestion headache and my hips hurt. I tested COVID-19 Positive on 04/03/2023 at 11PM. I contacted my physical on 04/04/2023 and had prescribed me Paxlovid. I presently feel better but I still have congestion runny nose and sore throat. I am still weak with slight shortness of breath. I still have no taste nor smell.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dyspnoea, Headache, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea
Clinical narrative: I had my vaccination on 10/14/2022. On 04/02/2023 I started to have a sore throat. On the evening of 04/03/2023 I had the worst sore throat of my life. I had congestion headache and my hips hurt. I tested COVID-19 Positive on 04/03/2023 at 11PM. I contacted my physical on 04/04/2023 and had prescribed me Paxlovid. I presently feel better but I still have congestion runny nose and sore throat. I am still weak with slight shortness of breath. I still have no taste nor smell.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I had my vaccination on 10/14/2022. On 04/02/2023 I started to have a sore throat. On the evening of 04/03/2023 I had the worst sore throat of my life. I had congestion headache and my hips hurt. I tested COVID-19 Positive on 04/03/2023 at 11PM. I contacted my physical on 04/04/2023 and had prescribed me Paxlovid. I presently feel better but I still have congestion runny nose and sore throat. I am still weak with slight shortness of breath. I still have no taste nor smell.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 84.0
Sex: M
Vaccine: COVID19-2
Symptoms: Nasopharyngitis, Oropharyngeal pain, Pyrexia, Respiratory tract congestion, Rhinorrhoea
Clinical narrative: We are pleased because we feel the vaccine did it's job. I just finished my 10 days of quarantine and semi quarantine. I felt a more than mild cold. I had a fever a couple of times. I am very pleased of how this vaccine held up.  I had a sore throat runny nose and congestion. I was prescribed Paxlovid and took it as prescribed. I feel fine
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 38.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: MODERNA BIVALENT WAS GIVEN INSTEAD OF THE MONOVALENT, PATIENT HAS NOT HAD HIS INITIAL SERIES
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 1.25
Sex: F
Vaccine: UNK
Symptoms: Discomfort, Drooling, Eczema, Impetigo, Irritability
Clinical narrative: This is a 16-month-old female born full-term via vaginal delivery with no contributing comorbidities brought in by mother complaining of skin rash for 2 days.  Patient was evaluated emergency department 2 days ago for postvaccine fever and teething.  Since discharge, mother states patient has been afebrile that she has noticed a diffuse rash.  Patient has not been scratching at the rash but appears to be in discomfort and is fussier than normal.  She reports recent increase drooling due to teething.  Patient received influenza vaccine within the last week.  There is no associated vomiting, diarrhea, cough.  She has not noted increased work of breathing.  Normal wet diapers and bowel movements.  Mother reviewed symptoms as moderate in nature and rash remains unchanged with over-the-counter medication. Patient states that the rash is getting worse.  Patient has no history of the same.   The potential cause of the rash is unknown. Perioral crusted vesicular rash.  Vesicular rash noted diffusely to trunk and extremities is described as maculopapular, blanching without vesicles or petechiae.  No crepitus , cellulitis, fluctuance or induration noted. Patient has rash that is consistent with a impetigo, eczema and viral rash and therefore will be discharged home. Patient has currently been stabilized in the emergency department. Patient is non-toxic appearing, well hydrated, and playful. Based on the history, exam, and any testing done, I don't suspect an emergency cause of rash such as cellulitis, necrotizing fasciitis, vasculitis etc. Patient will be discharged with strict return precautions and follow up with primary MD within 24 hours for further evaluation.
Age: 1.25
Sex: F
Vaccine: UNK
Symptoms: Pallor, Perioral dermatitis, Pyrexia, Rash, Rash macular
Clinical narrative: This is a 16-month-old female born full-term via vaginal delivery with no contributing comorbidities brought in by mother complaining of skin rash for 2 days.  Patient was evaluated emergency department 2 days ago for postvaccine fever and teething.  Since discharge, mother states patient has been afebrile that she has noticed a diffuse rash.  Patient has not been scratching at the rash but appears to be in discomfort and is fussier than normal.  She reports recent increase drooling due to teething.  Patient received influenza vaccine within the last week.  There is no associated vomiting, diarrhea, cough.  She has not noted increased work of breathing.  Normal wet diapers and bowel movements.  Mother reviewed symptoms as moderate in nature and rash remains unchanged with over-the-counter medication. Patient states that the rash is getting worse.  Patient has no history of the same.   The potential cause of the rash is unknown. Perioral crusted vesicular rash.  Vesicular rash noted diffusely to trunk and extremities is described as maculopapular, blanching without vesicles or petechiae.  No crepitus , cellulitis, fluctuance or induration noted. Patient has rash that is consistent with a impetigo, eczema and viral rash and therefore will be discharged home. Patient has currently been stabilized in the emergency department. Patient is non-toxic appearing, well hydrated, and playful. Based on the history, exam, and any testing done, I don't suspect an emergency cause of rash such as cellulitis, necrotizing fasciitis, vasculitis etc. Patient will be discharged with strict return precautions and follow up with primary MD within 24 hours for further evaluation.
Age: 1.25
Sex: F
Vaccine: UNK
Symptoms: Rash maculo-papular, Rash vesicular, Teething, Viral rash
Clinical narrative: This is a 16-month-old female born full-term via vaginal delivery with no contributing comorbidities brought in by mother complaining of skin rash for 2 days.  Patient was evaluated emergency department 2 days ago for postvaccine fever and teething.  Since discharge, mother states patient has been afebrile that she has noticed a diffuse rash.  Patient has not been scratching at the rash but appears to be in discomfort and is fussier than normal.  She reports recent increase drooling due to teething.  Patient received influenza vaccine within the last week.  There is no associated vomiting, diarrhea, cough.  She has not noted increased work of breathing.  Normal wet diapers and bowel movements.  Mother reviewed symptoms as moderate in nature and rash remains unchanged with over-the-counter medication. Patient states that the rash is getting worse.  Patient has no history of the same.   The potential cause of the rash is unknown. Perioral crusted vesicular rash.  Vesicular rash noted diffusely to trunk and extremities is described as maculopapular, blanching without vesicles or petechiae.  No crepitus , cellulitis, fluctuance or induration noted. Patient has rash that is consistent with a impetigo, eczema and viral rash and therefore will be discharged home. Patient has currently been stabilized in the emergency department. Patient is non-toxic appearing, well hydrated, and playful. Based on the history, exam, and any testing done, I don't suspect an emergency cause of rash such as cellulitis, necrotizing fasciitis, vasculitis etc. Patient will be discharged with strict return precautions and follow up with primary MD within 24 hours for further evaluation.
Age: 37.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Dyspnoea, Fatigue, Gait inability
Clinical narrative: On the evening of March 22, 2023, I was extremely tired. I was unable to walk up and down stairs without being exhausted. I was coughing and sneezing with nasal drip earlier in the week. I took NYQUIL to sleep. I slept for almost 19 hours. I was extremely tired and slept for three days. I had a little bit of muscle fatigue. I had head congestion that caused coughing and hard to breathe. I tested positive on the 23rd. I spoke to my doctor on that same night. I was able to complete the survey online and was prescribed PAXLOVID. I began to feel better after day 3 of PAXLOVID though I still had nasal drip.
Age: 37.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypersomnia, Muscle fatigue, Respiratory tract congestion, SARS-CoV-2 test positive, Sneezing
Clinical narrative: On the evening of March 22, 2023, I was extremely tired. I was unable to walk up and down stairs without being exhausted. I was coughing and sneezing with nasal drip earlier in the week. I took NYQUIL to sleep. I slept for almost 19 hours. I was extremely tired and slept for three days. I had a little bit of muscle fatigue. I had head congestion that caused coughing and hard to breathe. I tested positive on the 23rd. I spoke to my doctor on that same night. I was able to complete the survey online and was prescribed PAXLOVID. I began to feel better after day 3 of PAXLOVID though I still had nasal drip.
Age: 37.0
Sex: M
Vaccine: COVID19-2
Symptoms: Upper-airway cough syndrome
Clinical narrative: On the evening of March 22, 2023, I was extremely tired. I was unable to walk up and down stairs without being exhausted. I was coughing and sneezing with nasal drip earlier in the week. I took NYQUIL to sleep. I slept for almost 19 hours. I was extremely tired and slept for three days. I had a little bit of muscle fatigue. I had head congestion that caused coughing and hard to breathe. I tested positive on the 23rd. I spoke to my doctor on that same night. I was able to complete the survey online and was prescribed PAXLOVID. I began to feel better after day 3 of PAXLOVID though I still had nasal drip.
Age: 53.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 66.0
Sex: M
Vaccine: COVID19-2, FLUX
Symptoms: COVID-19, Cough, Fatigue, Patient isolation, Respiratory tract congestion
Clinical narrative: I had a little tenderness in the arm for about a day. I tested positive for COVID-19 on 12/05/2022. I had a massive runny nose, congestion, fatigue and cough. I reached out to my doctor but never heard back from her. I stayed home isolated, rested and stayed hydrated. As of today, I do not have any lingering COVID-19 symptoms.
Age: 66.0
Sex: M
Vaccine: COVID19-2, FLUX
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive, Tenderness
Clinical narrative: I had a little tenderness in the arm for about a day. I tested positive for COVID-19 on 12/05/2022. I had a massive runny nose, congestion, fatigue and cough. I reached out to my doctor but never heard back from her. I stayed home isolated, rested and stayed hydrated. As of today, I do not have any lingering COVID-19 symptoms.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 62.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: COVID-19, Chills, Cough, Ear discomfort, Hyperhidrosis
Clinical narrative: I had a stuffy nose that eventually led to a cough. On Tuesday night I threw up, I couldn't sleep, I had chills, sweating. On Wednesday, I was blowing my nose constantly, I had to fly home, could not get my ears to pop open, I did not go work on Thursday. I took a home COVID-19 test that came back positive. I was taking over the medication, everything seemed to be going away, then the cough came back with a vengeance. I was coughing so hard it was giving me a headache. I tried talking to my doctor, but he was running late, I talked to his nurse who suggested I try Mucinex DM. I took two full bottles. I am still coughing because of a lingering tickle in my throat.
Age: 62.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Impaired work ability, Insomnia, Nasal congestion, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: I had a stuffy nose that eventually led to a cough. On Tuesday night I threw up, I couldn't sleep, I had chills, sweating. On Wednesday, I was blowing my nose constantly, I had to fly home, could not get my ears to pop open, I did not go work on Thursday. I took a home COVID-19 test that came back positive. I was taking over the medication, everything seemed to be going away, then the cough came back with a vengeance. I was coughing so hard it was giving me a headache. I tried talking to my doctor, but he was running late, I talked to his nurse who suggested I try Mucinex DM. I took two full bottles. I am still coughing because of a lingering tickle in my throat.
Age: 62.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Throat irritation, Vomiting
Clinical narrative: I had a stuffy nose that eventually led to a cough. On Tuesday night I threw up, I couldn't sleep, I had chills, sweating. On Wednesday, I was blowing my nose constantly, I had to fly home, could not get my ears to pop open, I did not go work on Thursday. I took a home COVID-19 test that came back positive. I was taking over the medication, everything seemed to be going away, then the cough came back with a vengeance. I was coughing so hard it was giving me a headache. I tried talking to my doctor, but he was running late, I talked to his nurse who suggested I try Mucinex DM. I took two full bottles. I am still coughing because of a lingering tickle in my throat.
Age: 58.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it likely maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you may have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 4.0
Sex: F
Vaccine: HEPA
Symptoms: Extra dose administered
Clinical narrative: Patient had already completed the hep a series and didn't need this dose.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory distress syndrome, COVID-19 pneumonia, Condition aggravated, Death, Endotracheal intubation
Clinical narrative: sx 12-19-22    admitted at MED CENTER 1-2-23 ; expired on 1-27-23 He had ho heart TX/MDS/chronic immunospressants was admitted with multifocal pneumonia, covid pneumonia, resp failure.  intubated 1-15-23   Complicated course  developed ARDS,    renal failure did not tolerate crrt.   septic shock with vasopressors.   chronic pancytopenia and h/o ITP.   It was decided to give him comfort measures .
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Haemofiltration, Pancytopenia, Pneumonia, Renal failure, Respiratory failure
Clinical narrative: sx 12-19-22    admitted at MED CENTER 1-2-23 ; expired on 1-27-23 He had ho heart TX/MDS/chronic immunospressants was admitted with multifocal pneumonia, covid pneumonia, resp failure.  intubated 1-15-23   Complicated course  developed ARDS,    renal failure did not tolerate crrt.   septic shock with vasopressors.   chronic pancytopenia and h/o ITP.   It was decided to give him comfort measures .
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Septic shock
Clinical narrative: sx 12-19-22    admitted at MED CENTER 1-2-23 ; expired on 1-27-23 He had ho heart TX/MDS/chronic immunospressants was admitted with multifocal pneumonia, covid pneumonia, resp failure.  intubated 1-15-23   Complicated course  developed ARDS,    renal failure did not tolerate crrt.   septic shock with vasopressors.   chronic pancytopenia and h/o ITP.   It was decided to give him comfort measures .
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 21.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient was given bivalent booster rather than monovalent booster for their 2nd dose. Spoke with Pfizer, per CDC recommendations, patient is to not repeat the dose and to continue with recommended regimen. Patient is also aware of the vaccine mix-up and did not state of any ADR.
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: On 4/14/2023 upon reconciling the Covid Bivalent booster, it was noted that the vaccine given on 4.12 23 had expired on 4/3/2023.  Expiration date was incorrectly documented as 4/23/23.
Age: 75.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 65.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: Blood glucose increased, Full blood count normal, Low density lipoprotein decreased, Sensory disturbance, Therapy change
Clinical narrative: My doctor placed me on atorvastatin because I am diabetic. I had been on metformin since mid-November or December of 2022. In January of 2023, I was prescribed a small dose of atorvastatin once a day in the evening. The response was my morning blood sugar immediately jumped from my normal reading of 140 to 150 to 180 or better every morning. I couldn't think of anything else that changed aside from the atorvastatin. I contacted my doctor. I'm going in on Thursday. I stopped the atorvastatin about 10 days ago. My toes feel like they have cardboard pasted to them. It was worse than frostbite. It stayed like that all day. My blood sugar levels have lowered.
Age: 58.0
Sex: F
Vaccine: COVID19, FLUX
Symptoms: Asthma, COVID-19, Condition aggravated, Cough, Dysphonia
Clinical narrative: I had my vaccination on 10/14/2022. I started to have a runny hose and headache on 03/04/2023. I went to an appointment for a physical on 03/09/2023 and was told it was allergies. A few days later I had to leave work and go to the emergency room. I was given IV fluids and tested COVID-19 Positive on 03/12/2023. I was not provided medication as I was too young. I am still suffering from Asthma on 04/17/2023 and my voice is still hoarse with a dry cough.
Age: 58.0
Sex: F
Vaccine: COVID19, FLUX
Symptoms: Headache, Impaired work ability, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: I had my vaccination on 10/14/2022. I started to have a runny hose and headache on 03/04/2023. I went to an appointment for a physical on 03/09/2023 and was told it was allergies. A few days later I had to leave work and go to the emergency room. I was given IV fluids and tested COVID-19 Positive on 03/12/2023. I was not provided medication as I was too young. I am still suffering from Asthma on 04/17/2023 and my voice is still hoarse with a dry cough.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Pfizer reviewed the stability of the vaccine you received and determined that it likely did not maintain the activity necessary to protect against COVID-19 at time of administration. Pfizer cannot guarantee the protection you may have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you.
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Influenza
Clinical narrative: J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/30/2021 INFLUENZA
Age: 64.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: COVID-19, Cough, Influenza A virus test negative, Influenza B virus test, Oropharyngeal pain
Clinical narrative: I had a really bad cough, fever, sore throat, no respiratory symptoms. I called my doctor, made an appointment with my doctor who tested me for influenza A and B, it came back negative. My doctor told me to go home and test for COVID-19. I used a home COVID-19 test that came back positive. I called the doctor to let her know that my test did come back positive, she prescribed the PAXLOVID. It helped with the fever; I still have the cough. I think I felt good for maybe a day. The doctor told me I have rebound COVID-19 and eventually I would get better.
Age: 64.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I had a really bad cough, fever, sore throat, no respiratory symptoms. I called my doctor, made an appointment with my doctor who tested me for influenza A and B, it came back negative. My doctor told me to go home and test for COVID-19. I used a home COVID-19 test that came back positive. I called the doctor to let her know that my test did come back positive, she prescribed the PAXLOVID. It helped with the fever; I still have the cough. I think I felt good for maybe a day. The doctor told me I have rebound COVID-19 and eventually I would get better.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Septic shock
Clinical narrative: J96.00 ACUTE RESPIRATORY FAILURE 9/14/2022 SEPTIC SHOCK
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it likely maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you may have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chills, Hyperhidrosis, Insomnia, Pain, Pollakiuria
Clinical narrative: I had UTI and pain I had to get up and pee over and over again. I was going from chills to fevers and having hot sweats. I had spent the entire weekend like this. I wasn't getting any sleep and in pain. I had to wait until Monday for testing. I was given a urinalysis. Before the results got back, I had a script for the antibiotic. I am still taking the antibiotic and feeling. As of today, I am symptom free and almost back to normal.
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pyrexia, Urinary tract infection, Urine analysis
Clinical narrative: I had UTI and pain I had to get up and pee over and over again. I was going from chills to fevers and having hot sweats. I had spent the entire weekend like this. I wasn't getting any sleep and in pain. I had to wait until Monday for testing. I was given a urinalysis. Before the results got back, I had a script for the antibiotic. I am still taking the antibiotic and feeling. As of today, I am symptom free and almost back to normal.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 39.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Pt was given the Covid bivalent Boster on 4/5/23 and it had expired on 4/3/23
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 0.67
Sex: F
Vaccine: DTAPIPVHIB, IPV, PNC13
Symptoms: Extra dose administered
Clinical narrative: Pentacel was given as well as polio vaccine.  There were no symptoms.
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood test abnormal, Gene mutation, Platelet count increased
Clinical narrative: On 9/19/22, I had an annual physical and they noticed that my platelet count was a little high. I met with a Hematologist on 11/11/22, and they ran more tests. The determined that I have a gene mutation and my bone marrow is overproducing platelets and they are going to try to control it with medication. I was prescribed Hydroxyurea 3 days a week at first and now I am taking it 5 days a week. I am also taking a Baby Aspirin. No other medications were prescribed.  I am still dealing with this at this time.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Dyspnoea, Respiratory failure
Clinical narrative: ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 9/8/2022 SHORTNESS OF BREATH
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Breast discolouration, Breast inflammation, Mammogram normal, Ultrasound breast abnormal, Ultrasound breast normal
Clinical narrative: 2/9/2023   I noticed some discoloration on my left breast. I went to the gynecologist, and she sent me for a mammogram.  I was also prescribed an antibiotic. It took 2 weeks to get the appointment. On 3/1/2023   when I went for the Mammogram, the discoloration had gone down and I was told it  looked like cellulitis. I also had an ultrasound that showed inflammation. I was prescribed another week?s worth of antibiotic. I had a repeat Ultrasound on 4/12/23 and everything looked clear and good, and it is all gone.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 98.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was adminstered post expiration. A letter was sent to the patient's address on 2/17/2023 stating manufacturer's vaccine activity at the time of administration.   Manufacturer Statement: Moderna reviewed the stability of the vaccine you received and determined that it maintained the activity necessary to protect against COVID-19 at time of administration. Moderna cannot guarantee the protection you have received is equivalent to what was seen in studies and data is not available to support administering an additional dose of vaccine to you. However, if you wish to undergo revaccination, we will provide you access as outlined below.
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Haemoglobin decreased
Clinical narrative: Started developing dizziness and exhaustion that was diagnosed after significant decrease in Hemoglobin detected in blood panel.